Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging.
about
Gold nanoparticles for photoacoustic imagingIn Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles.Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution.Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance.Dual-radiolabeled nanoparticle SPECT probes for bioimaging.Intrinsically radioactive [64Cu]CuInS/ZnS quantum dots for PET and optical imaging: improved radiochemical stability and controllable Cerenkov luminescence.The surprising in vivo instability of near-IR-absorbing hollow Au-Ag nanoshellsDendrimer-Stabilized Gold Nanostars as a Multifunctional Theranostic Nanoplatform for CT Imaging, Photothermal Therapy, and Gene Silencing of Tumors.Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imagingComparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment.Biodistribution and fate of core-labeled 125I polymeric nanocarriers prepared by Flash NanoPrecipitation (FNP).Gold Nanoparticles Doped with (199) Au Atoms and Their Use for Targeted Cancer Imaging by SPECT.Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseasesLipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases.Nanometric gold in cancer nanotechnology: current status and future prospect.Advanced nuclear analytical and related techniques for the growing challenges in nanotoxicology.Emerging advances in nanomedicine with engineered gold nanostructures.Pharmacokinetics of metallic nanoparticles.Biomedical applications of gold nanomaterials: opportunities and challenges.Clearance Pathways and Tumor Targeting of Imaging NanoparticlesSurface-chemistry effect on cellular response of luminescent plasmonic silver nanoparticles.Putting gold nanocages to work for optical imaging, controlled release and cancer theranostics.(99m) Tc radiolabeling and biological evaluation of nanoparticles functionalized with a versatile coating ligand.Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of ⁶⁴Cu-Au alloy nanoclusters.Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 PET imaging of tumors and metastasesNanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.PEGylation and zwitterionization: pros and cons in the renal clearance and tumor targeting of near-IR-emitting gold nanoparticles.Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.Combined Positron Emission Tomography and Cerenkov Luminescence Imaging of Sentinel Lymph Nodes Using PEGylated Radionuclide-Embedded Gold Nanoparticles.Gold nanoparticles enlighten the future of cancer theranostics.Design and Modular Construction of a Polymeric Nanoparticle for Targeted Atherosclerosis Positron Emission Tomography Imaging: A Story of 25% (64)Cu-CANF-CombGlutathione-coated luminescent gold nanoparticles: a surface ligand for minimizing serum protein adsorption.Enhanced tumor accumulation of sub-2 nm gold nanoclusters for cancer radiation therapy.Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy.Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic.Gold nanostars co-coated with the Cu(II) complex of a tetraazamacrocyclic ligand.Recent advances in synthetic methods and applications of silver nanostructures.Silica-encapsulated gold nanoparticle dimers for organelle-targeted cellular delivery.Polyacrylonitrile/noble metal/SiO₂ nanofibers as substrates for the amplified detection of picomolar amounts of metal ions through plasmon-enhanced fluorescence.
P2860
Q26858831-FED23517-BD1B-43C5-A120-7135610E3651Q27342269-C33FB397-0A6E-4980-B8BF-30D8D5595929Q30413615-52342737-5CFB-4FFF-B81E-225FB5C571E4Q34023045-B184450F-889F-4BC8-B20B-4034BAB0A781Q34717335-C046948C-0EAF-4023-B509-6A72FB4C2F6DQ35027192-FB61C548-5083-40CE-B6AE-B15BE02ED627Q35096585-2AE57224-C974-4011-AD81-C0ABB854EE7EQ36207691-A9CC93E3-7B92-4012-8230-D1A1A84A0015Q36622418-1B7419E6-B346-4952-AFC1-D518BCFE9721Q36721837-68279BC9-CACE-40B3-8865-DEC223A564C4Q36783691-B89BE0BB-1214-4752-8B0A-68084FCE7D9AQ36813523-10AD4823-5644-42A6-80A5-8A0070BB0DBEQ37078082-A185881A-3CFE-48D5-90E5-DD5819EE32EBQ37731821-3F4726CA-6615-4841-8F3B-DC4EA320DB20Q38100196-490271AE-88F3-4CA2-95B6-FE4F100D73F1Q38122657-7B985B66-0096-4D4D-AC0E-A748A49EC216Q38180306-9CA7CD74-B473-442A-8177-86D0F7D4EF5DQ38260360-6A4B09FB-AD7A-468F-B26B-0897A680BD8CQ38391000-8DBAF001-7D1C-48CB-95F3-C0DE2BD09C16Q38543331-B29FF30E-5508-4D19-938B-4E9E0FCD5566Q38701931-789AABAD-7565-4994-8B2B-7AAEE33B1C08Q38878486-EE05D8EE-6CF9-4586-8DFF-D808C65768CAQ38900624-55B4562C-20F0-42F4-B14D-B3D929D5950EQ38926681-92FF18BB-BFE6-4281-A659-A4553AC55120Q38952273-26AAE75A-97CD-45D8-8804-5CF43478B881Q39065411-0CC84515-D0C8-4B9D-A5DD-2B8868DCE166Q39076542-E659FF26-451D-4ABD-AC34-7D8A115A1EE9Q39079349-C945275E-A8E4-47B6-BF54-A21D1F6918CCQ39104249-FA4107CA-E47D-41E4-B4F5-F49216126553Q39579062-B62B7471-2D5A-4F94-90E0-6491B08C9EC1Q41545901-C3D0037F-65F4-480C-BEE0-CA39374906D8Q41656026-70163D1C-7D0D-49D6-AEAA-468538A7B7E3Q41780540-271D1B98-92D4-423D-BA92-7238363D2610Q45899286-6796598D-1CD9-4C4D-BFAF-3A4848923DBEQ45986152-DAA28261-6573-4244-9770-DB67DE33B1C4Q48272615-9E98E792-0BD0-47D3-B75E-5F9AF8E909DAQ48683222-AD8796CA-ACA1-43A0-9A8E-995F207E8305Q49862723-BDDECF30-6F3C-4021-9DF7-E7A0A6D11ABEQ50909333-4AE7B122-99CE-4880-8B0C-9E9AA2AC9B70Q51026259-C6AF3726-2667-4CD6-AD72-160FE431E1FB
P2860
Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Evaluating the pharmacokinetic ...... n emission tomography imaging.
@ast
Evaluating the pharmacokinetic ...... n emission tomography imaging.
@en
type
label
Evaluating the pharmacokinetic ...... n emission tomography imaging.
@ast
Evaluating the pharmacokinetic ...... n emission tomography imaging.
@en
prefLabel
Evaluating the pharmacokinetic ...... n emission tomography imaging.
@ast
Evaluating the pharmacokinetic ...... n emission tomography imaging.
@en
P2093
P2860
P356
P1433
P1476
Evaluating the pharmacokinetic ...... n emission tomography imaging.
@en
P2093
Chad Jarreau
Hannah Luehmann
Michael Welch
Paige Brown
Yongjian Liu
Younan Xia
P2860
P304
P356
10.1021/NN300464R
P407
P577
2012-06-19T00:00:00Z